Jonathan Li
6Patents
2h-index
8Co-inventors
36Inventor score
Filing activity: Aug 20, 2014 → Feb 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10633440B2 | Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens | Emerging Cross-Sectional Technologies | 7 | Active |
| US10501552B2 | Multivalent molecules comprising DR5-binding domains | Chemistry; Metallurgy | 3 | Active |
| US9932400B2 | Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12338463B2 | Sindbis control virus | Chemistry; Metallurgy | 0 | Active |
| US11697684B2 | Tri-specific binding molecules that specifically bind to multiple cancer antigens | Emerging Cross-Sectional Technologies | 0 | Active |
| US10858430B2 | Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.